Dichloroacetate and metformin synergistically suppress the growth of ovarian cancer cells
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
// Bo Li 1, * , Xinzhe Li 1, * , Zhenhong Ni 1 , Yan Zhang 1 , Yijun Zeng 1 , Xiaohuan Yan 2 , Yan Huang 3 , Jintao He 4 , Xilin Lyu 1 , Yaran Wu 1 , Yuting Wang 1 , Yingru Zheng 2 , Fengtian He 1 1 Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Third Military Medical University, Chongqing 400038, China 2 Department of Obstetrics and Gynecology, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing 400042, China 3 Cancer Center, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing 400042, China 4 Battalion 17 of Students, College of Preventive Medicine, Third Military Medical University, Chongqing 400038, China * These authors have contributed equally to this work Correspondence to: Yingru Zheng, email: zyrdaping@aliyun.com Fengtian He, email: hefengtian06@aliyun.com Keywords: dichloroacetate, metformin, Mcl-1, cancer metabolism, ovarian cancer Received: January 24, 2016 Accepted: July 09, 2016 Published: July 19, 2016 ABSTRACT Both dichloroacetate (DCA) and metformin (Met) have shown promising antitumor efficacy by regulating cancer cell metabolism. However, the DCA-mediated protective autophagy and Met-induced lactate accumulation limit their tumor-killing potential respectively. So overcoming the corresponding shortages will improve their therapeutic effects. In the present study, we found that DCA and Met synergistically inhibited the growth and enhanced the apoptosis of ovarian cancer cells. Interestingly, we for the first time revealed that Met sensitized DCA via dramatically attenuating DCA-induced Mcl-1 protein and protective autophagy, while DCA sensitized Met through markedly alleviating Met-induced excessive lactate accumulation and glucose consumption. The in vivo experiments in nude mice also showed that DCA and Met synergistically suppressed the growth of xenograft ovarian tumors. These results may pave a way for developing novel strategies for the treatment of ovarian cancer based on the combined use of DCA and Met.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233 · cited 1×
“In recent years, the growing evidences have shown that cancer is a kind of metabolic abnormalities, which pushes it to the forefront by regulating cancer metabolism to inhibit tumor growth [3].”
BackgroundMaurer, U., Charvet, C., Wagman, A. S., Dejardin, E., & Green, D. R. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.02.009 · Cited by 881
Sahra, I. B., Laurent, K., Loubat, A., Giorgetti-Peraldi, S., Colosetti, P., Auberger, P., Tanti, J. F., Le Marchand-Brustel, Y., & Bost, F. (2008) · Oncogene · doi:10.1038/sj.onc.1211024 · Cited by 861
Metformin induces unique biological and molecular responses in triple negative breast cancer cells
Liu, B., Fan, Z., Edgerton, S. M., Deng, X.-S., Alimova, I. N., Lind, S. E., & Thor, A. D. (2009) · Cell Cycle · doi:10.4161/cc.8.13.8814 · Cited by 392
Domina, A. M., Vrana, J. A., Gregory, M. A., Hann, S. R., & Craig, R. W. (2004) · Oncogene · doi:10.1038/sj.onc.1207692 · Cited by 327
mTORC1 promotes survival through translational control of Mcl-1
Mills, J. R., Hippo, Y., Robert, F., Chen, S. M. H., Malina, A., Lin, C.-J., Trojahn, U., Wendel, H.-G., Charest, A., Bronson, R. T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804821105 · Cited by 285 · cited 1×
“It has been reported activation of mTOR promotes Mcl-1 translation [26], so we analyzed p-mTOR after cotreatment with Met and DCA.”
MethodChaube, B., Malvi, P., Singh, S. V., Mohammad, N., Meena, A. S., & Bhat, M. K. (2015) · Oncotarget · doi:10.18632/oncotarget.6134 · Cited by 80
Cited by
Metabolic adaptation in hypoxia and cancer
Paredes, F., Williams, H. C., & San Martin, A. (2021) · Cancer Letters · doi:10.1016/j.canlet.2020.12.020 · Cited by 259
Aloia, A., Müllhaupt, D., Chabbert, C. D., Eberhart, T., Flückiger-Mangual, S., Vukolic, A., Eichhoff, O., Irmisch, A., Alexander, L. T., Scibona, E., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0253 · Cited by 130
“DCA in combination with metformin, an OXPHOS inhibitor, synergistically suppressed tumor growth (47), while metformin and starvation reduced cancer progression in colon and breast cancer (48).”
BackgroundCui, Y., Zhou, J., & Rong, F. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.09.135 · Cited by 14
Hypoxic microenvironment in cancer: role in metabolic reprogramming
Sureka, N., Maheshwari, R., Agravat, A., Singhal, S., Zaman, S., Rishi, B., Siraj, F., Zaheer, S., & Misra, A. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1771365 · Cited by 11
“In vivo experiment in nude mice, co-administration of DCA and metformin signi fi cantly reduced tumor growth compared to either agent alone (244).”
Metadata
- Authors
- Li, B., Li, X., Ni, Z., Zhang, Y., Zeng, Y., Yan, X., Huang, Y., He, J., Lyu, X., Wu, Y., Wang, Y., Zheng, Y., & He, F.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-07-19
- Volume
- 7
- Issue
- 37
- Pages
- 59458-59470
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2498885669
- Cited by
- 55
- References
- 7
- FWCI
- 2.86
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dichloroacetate and metformin synergistically suppress the growth of ovarian cancer cells. https://app.cochat.ai/papers/10.18632/oncotarget.10694
- The paper
- Li, B., Li, X., Ni, Z., Zhang, Y., Zeng, Y., Yan, X., Huang, Y., He, J., Lyu, X., Wu, Y., Wang, Y., Zheng, Y., & He, F. (2016). Dichloroacetate and metformin synergistically suppress the growth of ovarian cancer cells. Oncotarget. https://doi.org/10.18632/oncotarget.10694
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.